Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „infants“
Suchtreffer
Begriffe & Kennungen
Comirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Omicron-adapted Comirnaty Infants 6 months to 23 months of age - after 2 doses In 2 groups from Study 6 (Phase
Eintrag öffnenComirnaty · 4.8 · Omicron-adapted Comirnaty Infants 6 months to 23 months of age - after 2 doses In 2 groups from Study 6 (Phase
Eintrag öffnenComirnaty · 4.8 · Omicron-adapted Comirnaty Infants 6 months to 23 months of age - after 2 doses In 2 groups from Study 6 (Phase
Eintrag öffnenComirnaty · 4.8 · Omicron-adapted Comirnaty Infants 6 months to 23 months of age - after 2 doses In 2 groups from Study 6 (Phase
Eintrag öffnenComirnaty · 4.8 · Omicron-adapted Comirnaty Infants 6 months to 23 months of age - after 2 doses In 2 groups from Study 6 (Phase
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in infants 6 to 23 months of age that received any primary course dose inc
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in infants 6 to 23 months of age that received any primary course dose inc
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in infants 6 to 23 months of age that received any primary course dose inc
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in infants 6 to 23 months of age that received any primary course dose inc
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in infants 6 to 23 months of age that received any primary course dose inc
Eintrag öffnenEntwicklungsrückschritte
Eintrag öffnenEylea · 4.8 · Adverse reactions established for adult indications are considered applicable to preterm infants with ROP, tho
Eintrag öffnenFoclivia · 4.8 · In infants and children 6 to 35 months of age, the most frequently reported (≥10%) adverse reactions were inje
Eintrag öffnenFoclivia · 4.8 · Ininfants and children 6 to 35 months of age, the most frequently reported (≥10%) adverse reactions were injec
Eintrag öffnenFrühgeborenes
Eintrag öffnenFrühgeburt
Eintrag öffnen